Delivery Order SPE2DB20D3101-SPE2DB24FQTP5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,344.44 firm-fixed-price delivery order is for the supply of Cevimeline Hydrochloride 30 mg capsules, a medication used to treat dry mouth. This specific award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,512.21, is for the delivery of 4566281332 CEVIMELINE HCL 30 MG CAPSULE 100S. The contract type is Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is October 31, 2024. This award is not designated as a set-aside. Amerisourcebergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,419.90 firm-fixed-price delivery order is for the procurement of 4562249886 CEVIMELINE HCL 30 MG CAPSULE 100S, a pharmaceutical product. The award is not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense and...
- The Defense Logistics Agency Troop Support Medical awarded a $122,760 delivery order to Amerisourcebergen Drug Corporation for 100 capsules of the pharmaceutical Cevimeline hydrochloride 30 mg. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD and other federal agencies. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by July 13, 2023. The firm fixed price...
- This is a $1,586.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of CEVIMELINE HCL 30 MG CAPSULE 100S, a prescription medication. The award is not designated as a set-aside contract. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,026.62 for the supply of CEVIMELINE HCL 30 MG CAPSULE 100S. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This contract is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and there...
- This contract award, valued at $3,254.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEVIMELINE HCL 30 MG CAPSULE 100S, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of December 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order valued at $13,885.61 for the supply of CEVIMELINE HCL 30 MG CAPSULE 100S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, has extensive experience providing pharmaceutical products and medical...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,918.00 firm fixed-price delivery order is for the supply of 4566374155 - CEVIMELINE HCL 30 MG CAPSULE 100S, a medication used to treat certain symptoms of Sjögren's syndrome. The contract has an ultimate completion date of November 8, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $857.67 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 100 capsules of the pharmaceutical Cevimeline hydrochloride 30mg. Performance will take place in Conshohocken, Pennsylvania over one day in July 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring and providing medical supplies and equipment to military...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQTP5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Cevimeline HCL 30 mg capsules. The $2,200.08 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 26, 2023. Amerisourcebergen Drug Corp is the prime contractor for this award, and it is not associated with any set-aside designation. The company's parent organization, Cencora, Inc., holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively. These IDCs enable Amerisourcebergen to efficiently deliver a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/25/23 |